Smith & Nephew's Advanced Wound Management division, Hull, UK, has signed an exclusive worldwide sales agreement with Covalon Technologies for its advanced range of collagen dressings. The agreement allows the distribution of the ColActive products based on Covalon's patented technology, and also grants access and distribution rights to a new product development portfolio in the field of advanced wound care using this technology.
[black up pointing small triangle] Information:http://www.smith-nephew.com
Derma Sciences, Inc, Princeton, NJ, has obtained a licensing agreement with C-Boot LTD, a medical biosystems company based in Israel, for the marketing, sales, and distribution rights of the company's patented therapeutic devices for the treatment of chronic venous insufficiency, venous ulcers, lymphedema, deep vein thrombosis prevention, and other conditions that require compression therapy. C-Boot's products will be marketed under the MOBILITY1 brand.
Rather than a therapy that is predicated on a patient being confined to the home, MOBILITY1 can be activated either by kinetic energy created from the patient walking or by a small, portable compressor (currently under review by the Food and Drug Administration). The device is designed to allow patients to maintain a regular lifestyle, taking therapy wherever they go.
[black up pointing small triangle] Information:http://www.dermasciences.com
Tempur-Pedic North America, Medical Division, Lexington, KY, has launched a new Web site, http://www.tempurmed.com, for consumers and customers looking for information on Tempur-Pedic medical products. The new site provides information on sleep; pressure management; diagnoses that affect sleep, such as fibromyalgia and restless leg syndrome; Tempur-Pedic clinical studies; and Tempur-Pedic press releases on medical division products.
[black up pointing small triangle] Information:http://www.tempurmed.com